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Background: Meningothelial cells (MECs) are the cellular components of the meninges. As such, they provide
important barrier function for the central nervous system (CNS) building the interface between neuronal tissue and
the cerebrospinal fluid (CSF), and are also part of the immune response of the CNS.
Methods: Human, immortalized MECs were analyzed by flow cytometry and confocal microscopy to study the
uptake of apoptotic cells. Furthermore, cytokine and chemokine production by MECs was analyzed by cytokine
array and ELISA.
Results: We found that MECs are highly active phagocytes able of ingesting and digesting large amounts of
apoptotic cells. Furthermore, the uptake of apoptotic cells by MECs was immune suppressive via inhibiting the
secretion of pro-inflammatory and chemoattractant cytokines and chemokines IL-6, IL-8, IL-16, MIF, and CXCL1,
while increasing the secretion of anti-inflammatory IL-1 receptor antagonist by MECs.
Conclusion: MECs respond with the secretion of anti-inflammatory cytokines and chemokines following the uptake
of apoptotic cells potentially connecting these cells to processes important for the shut-down of immune responses
in the brain.
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The central nervous system (CNS) is enveloped by a com-
plex layered structure, the meninges, providing protection
from outside influence. The meninges comprise dura
mater and the leptomeninges, which consist of the arach-
noid mater and pia mater together with the trabeculae
and septae that traverse the cerebrospinal fluid (CSF-)filled
subarachnoidal space [1,2]. The cellular component of
the pia, arachnoid, and the trabeculae and septae of the
subarachnoidal space are meningothelial cells (MECs)
also referred to as leptomeningeal cells [3]. MECs form
a monolayer and are connected via tight junctions, gap
junctions, and desmosomes contributing as part of the
pia mater to the barrier between the CSF and the neur-
onal tissue [4].
Recent work by us and others revealed several functions
of MECs beyond their function as cells simply covering
neuronal tissue. MECs were shown to be actively involved* Correspondence: albert.neutzner@unibas.ch
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unless otherwise stated.in physiological and pathophysiological processes in the
subarachnoidal space and in the CSF compartment [5-7].
Namely, MECs were shown to influence subarach-
noidal architecture during glaucomatous neurodegenera-
tion through increased proliferation [8] and to modulate
CSF composition under pathological conditions through
the production of lipocalin-type prostaglandin D synthase
[9]. Furthermore, MECs release pro-inflammatory cy-
tokines under pathophysiologically relevant conditions
such as oxidiative stress, increased pressure, or exposure
to lipopolysaccharide [5]. In addition, MECs proved to be
highly active facultative phagocytes capable of ingesting
large amounts of particulate matter such as latex beads
[5], but also Gram-positive and Gram-negative bacteria
[10]. Thus, MECs can be considered a part of the CNS
immune system.
Programmed cell death or apoptosis is essential for
maintaining tissue homeostasis during development [11]
and also occurs as part of immune cell maturation and
during the termination of the immune response [12]. As
final step of the apoptotic program, the correct disposalhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 MECs take up apoptotic cells. Primary porcine MECs were incubated with CFSE-labeled apoptotic U-937 (A) or SH-SY5Y (B) cells for 4
h at a MEC:apoptotic body ratio of 1:5. Fixed MECs were permeabilized, actin was stained using phalloidine-rhodomine, and cells were analyzed
by confocal microscopy. The right panel represents a 3D-reconstruction and a XYZ-view of the left panel. Ben-Men-I cells were incubated with
CFSE-labeled apoptotic U-937 (C) or SH-SY5Y (D) cells for 4 h at a MEC:apoptotic body ratio of 1:5 and analyzed as above. (E) CellTrace
Violet-labeled live Ben-Men-I cells were incubated with CFSE-labeled apoptotic U-937 cells and confocal images were taken at 0, 60, and 120 min.
The pictures show a representative time course of apoptotic body uptake (marked with *) by MECs.
Li et al. Journal of Neuroinflammation 2014, 11:35 Page 3 of 13
http://www.jneuroinflammation.com/content/11/1/35of apoptotic bodies via phagocytosis is essential, as apop-
totic cells might otherwise be a source for autoantigens
[13]. Thus, engulfment of apoptotic bodies is a mechan-
ism to prevent otherwise detrimental inflammatory re-
sponses leading to autoimmune disease. Interestingly,
uptake of apoptotic cells by phagocytes was shown to
have a direct anti-inflammatory effect by blunting pro-
inflammatory cytokine secretion of phagocytic cells fur-
ther preventing inflammation as response to apoptotic
cells [14].
Here we found that human MECs are capable of
ingesting apoptotic cells efficiently via the endosomal
route for digestion in the lysosomal compartment. Fur-
thermore, MECs react to the uptake of apoptotic cells
by decreasing their pro-inflammatory cytokine and
chemokine secrection, while at the same time increas-
ing the production of anti-inflammtory molecules sug-
gesting that MECs are able to act anti-inflammatory
and are involved in keeping immune-reactions in the
CNS in check.
Materials and methods
Cell culture and treatments
Human WHO grade I meningioma derived, hTERT im-
mortalized (Ben-Men-I) cells [15] were cultured in DMEM
supplemented with 10% FCS, 2 mM L-glutamine, and
1 mM sodium pyruvate (Sigma-Aldrich). Primary porcine
meningothelial cells (PMECs) were cultured as described
previously by us [16]. Monocyte-like U-937 cells (Sigma-
Aldrich, 85011440) were cultured in RPMI 1640 supple-
mented with 10% FCS, 2 mM L-glutamine, and 1 mM
sodium pyruvate (Sigma-Aldrich). SH-SY5Y cells were
cultured in DMEM supplemented with 15% FCS, 2 mM
L-glutamine, and 1 mM sodium pyruvate. Ben-Men-I cells
were treated with 0, 50, or 100 ng/mL of IL-6 (Sigma-
Aldrich, SRP3096) or IL-8 (Sigma-Aldrich, I1645). For up-
take studies, cells were incubated for 4 or 14 h with Alexa
Fluor 488-labeled, heat- or chemically-killed Staphylococcus
aureus (Invitrogen, S-23371) or apoptotic cells.
Generation of fluorescently-labeled apoptotic bodies
1 × 106 live U-937 or SH-SY5Y cells were stained with
0.5 μM CellTrace CSFE (Invitrogen, C34554) or Cell-
Trace Violet (Invitrogen, C34557) in PBS for 15 min at
37°C in the dark, incubated for 30 min in complete
medium at 37°C, washed. and resuspended in PBS. Morethan 99% of the cells were stained with CFSE as evalu-
ated by flow cytometry (Additional file 1: Figure S3B).
106 CFSE-labeled U-937 cells were resuspended in 10
mL of complete medium and treated with 700 ng/mL
actinomycin D (Sigma-Aldrich, A9415) for 20 h and
washed twice with PBS. SH-SY5Y cells were treated with
900 ng/mL actinomycin D for 24 h to induce apoptosis.
Using annexin V staining and propidium iodide exclusion,
induction of apoptosis was confirmed (Additional file 1:
Figures S3C).
Flow cytometric analyses
For the determination of phagocytic activity, Ben-Men-I
cells were seeded at 5 × 104 cells and grown in 3 mL of
media in six well flat-bottom cell culture plates for 24 h.
Following incubation with CFSE-labeled apoptotic U-937
or SH-SY5Y cells at the indicated ratios, cells were har-
vested using trypsin/EDTA, washed three times with
FACS buffer (10 mM EDTA, 1% FBS in PBS), resuspended
in FACS buffer before acquisition using a CyAnADP flow
cytometer (Beckman Coulter).
Microscopy
For detection of phagocytosis, Ben-Men-I cells or PMECs
were grown on glass cover slips for 24 h, incubated with
CFSE-labeled apoptotic cells for 4 h, washed five times
with PBS, and fixed with 4% paraformaldehyde in PBS pH
7.4 for 15 min at RT. Cells were washed three times with
PBS, permeabilized with 0.1% Triton X-100 in PBS for 15
min, and incubated in a blocking solution containing 10%
BSA in PBS for 1 h at RT. F-actin staining was performed
overnight at 4°C by incubating samples with rhodamine-
phalloidine (1:500, Sigma-Aldrich, P1951) in 1% BSA in PBS.
Before mounting using VectaShield (Vector Laboratories),
samples were washed five times with PBS.
For live cell imaging, CellTrace Violet-labeled Ben-
Men-I cells were grown for 24 h on chambered cover-
glass (Nunc Lab-Tek, 154461) at a densitiy of 5 × 103
cells/well in 1 mL of culture medium before addition
of CFSE-labeled apoptotic bodies. Z-stack confocal images
(Zeiss, LSM710Meta equipped with live cell imaging cham-
ber) were acquired every 15 min.
For indirect immunofluorescence, cells were grown on
glass cover slips, fixed at RT with 4% paraformaldehyde
in PBS for 15 min before permeabilization with 0.1%
Triton X-100 in PBS for 15 min and blocking (10% BSA
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against LAMP-1 (1:100, abcam, ab25630) or EEA-1
(1:500, abcam, ab70521) was performed overnight at 4°C
in 1% BSA in PBS. Samples were washed five times, incu-
bated for 2 h with secondary antibody Alexa Fluor® 546
goat anti-mouse IgG (1:500, Molecular Probes, A11030),
and washed three times with PBS, couterstained using
DAPI, before mounting with VectaShield.
To estimate phagosomal pH, cells were allowed to
internalize particles and were labeled with 50 nM Lyso-
Tracker Deep Red (Molecular Probes, L12492) for 15
min before fixation with 4% paraformaldehyde in PBS
and analysis by fluorescence microscopy.Figure 2 Time-dependent uptake of apoptotic bodies by MECs. (A) Be
for 4, 12, or 24 h at a MEC:apoptotic body ratio of 1:5. CFSE-fluorescence w
percentage of CFSE-positive MECs (left graph) and the mean fluorescence
the error bars representing SD. Statistical significance was analyzed by one
according to Holm for all comparisons (marked ***) except where noted oDetection of cytokines/chemokines
Ben-Men-I cells were seeded at a concentration of 6 ×
104/mL in DMEM medium and incubated with unlabeled
apoptotic cells. After 24 h, the culture supernatants were
harvested, centrifuged at 1,000 rpm for 5 min, and assayed
for IL-6, IL-8 (Orgenium Laboratories), IL-1RA (R&D,
DRA00B), IL-16 (RayBiotech, ELH-IL16-001), MIF (Ray-
Biotech, ELH-MIF-001), or CXCL1 (R&D, DRG00) by
ELISA. Cytokines present in apoptotic body preparations
were measured and background subtracted. The assays
were performed according to the manufacturers’ instruc-
tions. Absorbance was read on a Spectramax GEMINI XS
microplate reader (450 nm). For multiplexed detection ofn-Men-I cells were incubated with CFSE-labeled apoptotic U-937 cells
as analyzed using flow cytometry. The bar graphs (B) depict the
intensity (MFI - right graph) of three independent experiments with
-way ANOVA. Pair-wise Student’s t-test revealed P <0.001 adjusted
therwise (n.s. P >0.05).
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(R&D, ARY005) was used according to manufacturers’
recommendations.Statistical analyses
The program R [17] was employed for statistical ana-
lyses. One-way ANOVA was used to compare different
groups. In case ANOVA indicated significance, signifi-
cance levels were determined using pair-wise Student’s
t-tests with P values adjusted according to Holm. Sig-
nificance is reported as follows: P <0.1 marked with #;
P <0.05 marked with *; P <0.01 marked with **; P <0.001
marked with ***.Figure 3 Dose-dependent uptake of apoptotic bodies by MECs. (A) Be
for 4 h at a MEC:apoptotic body ratio of 1:0, 1:1, 1:5, 1:7, 1:10, and 1:15. CFS
(B) depict the percentage of CFSE-positive MECs (left graph) and the mean
experiments with the error bars representing SD. Statistical significance wa
P <0.001 adjusted according to Holm for all comparisons (marked ***) exceResults
Primary meningothelial cells derived from porcine optic
nerves (PMECs) [16] were incubated with apoptotic
bodies derived from monocytic U-937 or neuron-like
SH-SY5Y cells and the uptake of apoptotic bodies was
analyzed by confocal microscopy (Figure 1) as well as
flow cytometry (Additional file 1: Figure S1). Primary
MECs were found to actively ingest apoptotic bodies
derived from monocytic (Figure 1A) as well as neuronal-
like cells (Figure 1B). For further studies, Ben-Men-I
cells were employed as model for meningothelial cells as
they closely resemble MECs (Additional file 1: Figure S2,
[6]). To analyze the capacity of MECs to ingest apoptotic
cells, Ben-Men-I cells were incubated with CFSE-labeledn-Men-I cells were incubated with CFSE-labeled apoptotic U-937 cells
E-fluorescence was analyzed using flow cytometry. The bar graphs
fluorescence intensity (MFI - right graph) of three independent
s analyzed by one-way ANOVA. Pair-wise Student’s t-test revealed
pt where noted otherwise (** P <0.01).
Figure 4 (See legend on next page.)
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Figure 4 Uptake of apoptotic neuronal cells by MECs. (A) CellTrace Violet-labeled Ben-Men-I cells were incubated with CFSE-labeled apoptotic
SH-SY5Y cells for 4 (middle panel) and 24 (right panel) h at a MEC:apoptotic body ratio of 1:5. CellTrace violet and CFSE-fluorescence was analyzed
using flow cytometry. MECs not incubated with apoptotic bodies (left panel) served as control. (B) CFSE-labeled neuroblastoma-derived apoptotic
bodies were incubated with CellTrace Violet-labeled Ben-Men-I cells at a ratio of 1:0, 1:1, 1:5, 1:10 for 24 h and cellular uptake was analyzed by
flow cytometry. Shown is the average of three independent experiments with error bars depicting SD. Statistical significance was analyzed by
one-way ANOVA. Pair-wise Student’s t-test revealed P <0.001 adjusted according to Holm for all comparisons (marked ***).
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S3A, B) or neuron-like SH-SY5Y cells (Additional file 1:
Figure S3C), and the uptake of these apoptotic bodies
(Additional file 1: Figure S3D) by MECs was analyzed
using confocal microcopy and flow cytometry. As shown
in Figure 1, incubation of Ben-Men-I cells with apop-
totic bodies derived at a ratio of 1:5 resulted in the en-
gulfment of apoptotic cells by MECs (Figure 1C,D). The
uptake of apoptotic cells by MECs seems to be a two-
step process with a binding phase where apoptotic bod-
ies are situated on the outside of the plasma membrane
of MECs and an engulfment phase as shown using time
lapse live-cell confocal microscopy (Figure 1E). To fur-
ther define the time course of apoptotic cell uptake by
MECs, Ben-Men-I cells were incubated for 4, 12, and 24
h with a five-fold excess of apoptotic U-937 cells. Flow
cytometric analysis revealed a strong time-dependence
of apoptotic cell uptake from 26.5 +/- 1.1% to 60.7 +/-
1.8% apoptotic cell-positive MECs at 4, 12, and 24 h, re-
spectively (Figure 2A and B). Along with the increased
number of phagocytotically active cells at later time
points (Figure 2B, left graph), the amount of apoptotic
bodies taken up also increases over time as evident by
increased mean fluorescence intensity (MFI) at the 12-h
time point and reaches a plateau after 24 h (Figure 2B,
right graph).
Next, to quantify the capacity of MECs for apoptotic
U-937 cell uptake, Ben-Men-I cells were incubated with
apoptotic cells for 24 h at increasing MEC:apoptotic cell
ratios of 1:1, 1:5, 1:7, 1:10, and 1:15, and the amount of
engulfed fluorescent U-937 cells was analyzed by flow
cytometry. As shown in Figure 3, MECs displayed a
dose-dependent increase of apoptotic U-937 uptake with
around 15% of positive cells 1:1 ratio and about 85% of
phagocytotically active MECs at the 1:10 and the 1:15
MEC:apoptotic cell ratio. To analyze the uptake of apop-
totic neuronal cells by MECs, Ben-Men-I cells were in-
cubated with dying SH-SY5Y cells for 4 and 24 h as well
as different MEC:apoptotic cell ratios of 1:1; 1:5, and
1:10, respectively. As for U-937-derived apoptotic bod-
ies, Ben-Men-I cells displayed a time- (Figure 4A) and
dose-dependent (Figure 4B) uptake of SH-SY5Y-derived
apoptotic bodies. While 17.5 +/- 0.6% of MECs were
phagocytotically active at the 4-h time point, 72.8 +/-
2.1% of Ben-Men-I cells were capable of ingesting dying
neuronal cells at 24 h. Also as with apoptotic U-937cells, MECs displayed a high capacity for the uptake of
apoptotic neuronal cells as indicated by the increased
MFI at 24 h compared to 4 h and the high number of
phagocytotically active cells even at intermediate MEC:
apoptotic body ratios.
To analyze the fate of apoptotic bodies following inges-
tion by MECs, co-localization studies between markers of
the early and late endocytic as well the lysosomal compart-
ment were performed. To this end, MECs allowed to in-
gest apoptotic bodies for 5 min were fixed at the indicated
time points and were stained for the early endocytic
marker early endosome antigen 1 (EEA-1), the late endo-
somal/lysosomal marker lysosomal-associated membrane
protein 1 (LAMP1), or the lysotropic and pH-indicating
dye LysoTracker. Apoptotic bodies could already be
found 5 min after ingestion in EEA-1 positive vesicles
(Figure 5A), while LAMP1 was evident 30 min follow-
ing ingesting co-localization between apoptotic bodies
(Figure 5B). As evident by LysoTracker staining and
consistent with LAMP1 co-localization, acidification of
apoptotic body-containing vesicles was observed at the
30-min as well as 60-min time points (Figure 5C). These
data are consistent with the uptake of apoptotic bodies
by MECs and their subsequent digestion in the lyso-
somal compartment.
MECs are active participants in immunological pro-
cesses in the brain via cytokine and chemokine secre-
tion. To assess whether ingestion of apoptotic bodies
modulates this role, the response to cytokine treatment
of MECs as well as cytokine and chemokine secretion by
MECs was measured. Treatment with increasing con-
centrations of IL-6 did not significantly influence the
ability of MECs to ingest apoptotic bodies (Figure 6A),
while the same treatment was able to increase ingestion
of Gram-positive S. aureus bacteria, a known substrate
for MEC phagocytosis [10]. As for treatment with IL-8,
no alteration in the ability of MECs to ingest apoptotic
bodies was observed between untreated and IL-8 treated
cells, while IL-8 slightly increased the ingestion of S.
aureus particles (Figure 6B).
Uptake of apoptotic cells by professional phagocytes
results in alterations of their cytokine and chemokine
profile. To assess whether MECs resemble professional
phagocytes in this aspect, their cytokine profile in re-
sponse to apoptotic cell uptake, phorbol 12-myristate
13-acetate (PMA), or lipopolysaccharide (LPS) treatment
Figure 5 (See legend on next page.)
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Figure 5 Apoptotic bodies are taken up by MECs into the lysosomal compartment. Ben-Men-I cells were pulsed with CFSE-labeled
apoptotic U-937 cells for 5 min before fixation at the indicated time point. Subcellular localization of apoptotic bodies inside MECs was analyzed
using confocal microscopy at the indicated time points by staining against the early endosomal marker EEA-1 (A), the late endosomal/lysosomal
marker LAMP-1 (B), or by using LysoTracker (C) as marker for acidified lysosomal compartments. Please note the co-localization of apoptotic
bodies (labeled green) with the early endosomal marker EEA-1 (red) at early time points as well as the overlap between apoptotic cells and
lysosomal markers (LAMP-1 and LysoTracker - red) in later time points.
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with PMA or LPS or allowed to ingest apoptotic cells
were analyzed for 36 different cytokines and chemokines
using a multiplexed, antibody array (Figure 7A). Com-
pared to untreated control cells, treatment with PMA
known to impact cytokine production caused the upreg-
ulation of C5/C5a, CD40L, GMCSF, CXCL1, CD54,
IFN-γ, IL-6, IL-8, IL-17E, MCP-1, and sTREM-1, while
MIF and PAI-1 secretion was diminished. Treatment of
MECs with LPS known to elicit a pro-inflammatory
response caused the increased secretion of GMCSF,
CXCL1, IL-8, and MCP-1, while CD40L, IFN-γ, and MIF
production was decreased. As for cytokine production
following apoptotic body uptake, secretion of IL-1 re-
ceptor antagonist, IL-16, and MIF was increased, whileFigure 6 Bacterial but not apoptotic body uptake by MECs is increase
with 0, 50, or 100 ng/mL of IL-6 (A) or IL-8 (B) were incubated with CFSE-la
(right graphs) and particle uptake was determined using flow cytometry. S
bars representing SD. Statistical significance was analyzed by one-way ANO
according to Holm (* P <0.05).CD40L, CXCL1, and IL-8 production by MECs was
diminished.
To confirm observations made using the multiplex cyto-
kine antibody array and to assess changes of candidate cy-
tokines, levels of cytokines were independently determined
using specific ELISA (Table 1). Although below detection
level in the cytokine array in control cells, but based on
our previous observations, levels of IL-6 in control cells
and following uptake of apoptotic bodies was analyzed and
found to significantly decrease to 55.6 +/- 4.8% and 48 +/-
3.7% following ingestion of apoptotic cells at ratios of 1:1
or 1:5, respectively (Figure 7B, Additional file 1: Table S1).
To control for cytokine production by non-apoptotic
U-937 cells in our preparations of apoptotic bodies, IL-6
produced in these apoptotic body preparations wasd following pro-inflammatory treatment. Ben-Men-I cells treated
beled apoptotic U-937 (left graphs) or fluorescently-labeled S. aureus
hown is the average of three independent experiments with the error
VA. P values were determined using pair-wise Student’s t-test adjusted
Figure 7 (See legend on next page.)
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Figure 7 MECs alter their cytokine and chemokine secretion profile upon uptake of apoptotic bodies. (A) Ben-Men-I cells were treated
with PMA, LPS, and left untreated or were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:5 for 24 h. Cell culture supernatants were
analyzed for 36 different cytokines and chemokines using an antibody array. The array is organized in five rows (A-E) and 10 columns (1-10) with
two spots for each analyte (R = positive control, N = negative control). Please note that spots corresponding to IL-1 receptor antagonist (marked
with %) were weak but distinguishable to the eye. Differences in cytokine secretion between control and treatment groups are depicted in
qualitative heat maps. (B) Ben-Men-I cells were incubated with unlabeled apoptotic U-937 cells at a ratio of 1:1 or 1:5 for 24 h and the concentration
of IL-6 in culture supernatant was measured by ELISA. IL-6 was measured in supernatant of apoptotic cells and subtracted as background from
MECs treated with apoptotic cells. Shown is the average of three independent experiments with the error bars representing SD. Statistical
significance was assessed using Student’s t-test (*P <0.05). Ben-Men-I cells were treated as in (B) and with concentrations of (C) IL-8, (D) Il-16,
(E) CXCL1, (F) MIF (# represents P = 0.067), and (G) IL-1 receptor antagonist were measured by ELISA. Shown is the average of three independent
experiments with the error bars representing SD. Statistical significance was analyzed by one-way ANOVA. P values were determined using
pair-wise Student’s t-test adjusted according to Holm (# P <0.1; * P <0.05; ** P <0.01; *** P <0.001). Marked are the comparisons between the
control (1:0) and treatment groups.
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ground. Similarly, ingestion of apoptotic cells did blunt IL-
8 (Figure 7C, Additional file 1: Table S1), IL-16 (Figure 7D,
Additional file 1: Table S1), CXCL1 (Figure 7E, Additional
file 1: Table S1), and MIF (Figure 7F, Additional file 1:
Table S1) production by MECs. Again, measurement of
cytokine content in the supernatant of apoptotic cells was
performed and was subtracted as background. Incubation
of MECs at ratios of 1:1 and 1:5 decreased IL-8 secre-
tion to 80 +/- 8.1% and 71.8 +/- 4.3%, IL-16 secrection
to 78.9 +/- 19.4% and 42.46 +/- 8.3%, CXCL1 secretion
to 62.2 +/- 2.7% and 52.2 +/- 1.3%, while secretion of MIF
dropped to 36 +/- 45.8% and 35.7 +/- 45.6%, respectively.
As for the anti-inflammatory IL-1 receptor antagonist,
incubation of MECs with apoptotic bodies at a 1:5 ratio
resulted in a strong increase from below detection limit in
control cells to 15.9 +/- 3.5 pg/mL in MECs ingesting
apoptotic bodies (Figure 7G). As for monocyte-derived
apoptotic cells, the uptake of neuroblastoma-derived
apoptotic bodies also caused altered cytokine secretion
of MECs and a decrease in IL-6 and IL-8 secretion by
MECs was observed (Additional file 1: Figure S5).
Discussion
Phagocytosis is a complex cellular event by which large
particles are actively recognized, engulfed, and degraded
[18]. Phagocytosis is performed by professional phago-
cytes such as macrophages, neutrophils, or dendritic
cells, but other cells such as fibroblasts, epithelial,Table 1 Uptake of apoptotic bodies alters cytokine
secretion profile of MECs
Cytokine (pg/mL) MEC:apoptotic body ratio
1:0 1:1 1:5
IL-6 13.8 +/- 2.2 9.1 +/- 0.5 8.5 +/- 0.7
IL-8 368.2 +/-32.8 294.6 +/-29.9 264.2 +/-15.6
IL-16 117.8 +/- 15.6 92.9 +/- 31.3 50 +/-7
CXCL1 62.9 +/- 6.8 39.1 +/- 1.7 32.8 +/- 0.8
MIF 89 +/- 17.3 32 +/-25.4 31.7 +/-25.1endothelial, and smooth muscle cells are also capable of
taking up particulate matter [19-21]. The main function
of phagocytosis is the clearance of unwanted material,
for example, pathogens from the body as part of host
defense mechanisms. However, besides the removal of
pathogens, the orderly disposal of apoptotic cells as they
occur during tissue remodeling, normal cell turnover or
in the aftermath of a successfully battled infection is
achieved via phagocytosis [21]. Therefore it is conceiv-
able that MECs and their ability to clear apoptotic cells
might be important during tissue remodeling processes
in the brain for example during neurodegenerative disor-
ders. While microglia is known to clear apoptotic neur-
onal cells [22], under certain circumstances also MECs
might assist in this task. As MECs form a tight mono-
layer and are to our knowledge not motile, MECs might
only clear dying cells located on the periphery of the
neuronal tissue in close proximity to MECs covering the
pia mater. Therefore, such a mechanism might be more
prevalent in areas of the CNS such as the optic nerve
with its small volume compared to MEC surface than in
other parts of the brain with a larger volume of neuronal
tissue. Interestingly, MECs were shown to react to
pathological conditions during the course of glaucomat-
ous optic nerve degeneration [8]. Aside from apoptotic
cells inside neuronal tissue, all apoptotic bodies some-
how entering the CSF compartment are likely subject to
phagocytosis by MECs, as the specialized architecture of
the subarachnoidal space with its extensive trabeculae
and septa covered by MECs provides a large surface,
thus greatly boosting the contact interface between these
cells and the CSF. Although mounting evidence supports
phagocytosis by MECs [5,6,10], whether these cells per-
form uptake of apoptotic bodies in situ is unclear and
further in vivo studies beyond the scope of this study are
necessary to address this question.
Beyond this potential role of MECs in tissue remodel-
ing, removal of apoptotic cells by MECs is likely import-
ant to prevent the accumulation of apoptotic debris
which might lead to autoimmunity due to the increased
Li et al. Journal of Neuroinflammation 2014, 11:35 Page 12 of 13
http://www.jneuroinflammation.com/content/11/1/35presence of autoantigens as observed, for example, dur-
ing systemic lupus erythematosus [23]. We previously
showed a pro-inflammatory reaction of MECs where
stimulation with the Gram-negative bacteria-derived
danger signal lipopolysaccharide resulted in the in-
creased secretion of IL-6 and IL-8 [5]. Furthermore, we
implicated MECs in the clearance of Gram-positive and
Gram-negative bacteria from the CSF compartment, to-
gether establishing an immunological role for MECs in
the CNS [10]. Now we find that MECs are also capable
of ingesting apoptotic cells via the endocytotic pathway
and that uptake leads to a decrease of IL-6, IL-8, IL-16,
MIF, and CXCL1 production, while levels of IL-1 recep-
tor antagonist, are increasing. IL-6 [24], IL-8 [25],
CXCL1 [26], MIF [27], and IL-16 [28] are known to
act pro-inflammatory or immune response stimulating,
while IL-1 receptor antagonist [29] is known as anti-
inflammatory cytokine. As MECs are capable of secreting
various pro-inflammatory cytokines in response to PMA
treatment or following exposure to LPS via an NF-kB-
dependent mechanism as reported by us [5] supporting a
role for these cells during inflammation, the alteration of
cytokine and chemokine production following apoptotic
body uptake suggests that MECs can acts also in an anti-
inflammatory manner. Thus, the downregulation of pro-
inflammatory IL-6, IL-8, IL-16, MIF, and CXCL1 together
with the upregulation of anti-inflammatory IL-1 receptor
antagonist following uptake of apoptotic cells is consistent
with an anti-inflammatory role of MECs.
Thus, the data presented here together with previous
findings of a pro-inflammatory role of MECs point to an
integral role of MECs in immunological processes in the
CNS, both in the initiation and the shutdown of immune
reactions. Following infiltration of the CSF compartment
by immune cells during the course of an infection, clear-
ance of such cells and the shut-down of the immune re-
action is likely especially important in the CNS, as
unchecked immunological processes might lead to ser-
ious neurological damage.
Taken together, besides their clear role in physically
enveloping and protecting the CNS and their function in
the immunological protection of the brain during bacter-
ial infection, MECs might be involved in clearing apop-
totic cells during neurodegenerative disorders and are
likely important for keeping immunological defense
mechanisms in the CSF through the secretion of anti-
inflammatory cytokines.Additional file
Additional file 1: Figure S1. Uptake of apoptotic monocytic and
neuronal apoptotic bodies by primary MECs. Figure S2. Ben-Men-I cells
are a faithful model for MECs. Figure S3. (A) Labeling of cells using CFSE.
U-937 cells were labeled using CFSE and labeling efficiency wasdetermined using FACS analysis to be around 99%. Figure S4.
Size-difference is sufficient to distinguish between apoptotic U-937 and
Ben-Men-I cells. Figure S5. PMECs were incubated with unlabeled
apoptotic SH-SY5Y cells at a ratio of 1:1 or 1:5 for 24 hours and the
concentration of IL-6 (A) and IL-8 (B) in culture supernatant was
measured by ELISA.
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